Top Markets
#1 Black Phoenix Black Phoenix +354.94%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +68.90%
#4 OpenEden OpenEden +67.50%
#5 Akedo Akedo +50.90%
#6 BasedHype BasedHype +26.45%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +19.93%
#9 Humanity Humanity +18.04%
#10 Ether.fi Ether.fi +17.36%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
IR-Med Inc. IR-Med Inc.

IR-Med Inc.

IRME
株式のランク #40380
IR-Med Inc. is an emerging medical technology firm dedicated to developing... IR-Med Inc. is an emerging medical technology firm dedicated to developing advanced diagnostic and medical solutions by leveraging a platform that integrates infra-red light spectroscopy with artificial intelligence. The company's product pipeline includes PressureSafe, a handheld optical monitoring device engineered for the early identification of pressure-induced tissue damage in the skin and subcutaneous layers, often resulting from extended periods of patient immobility. Additionally, IR-Med is developing Nobiotics, an innovative otoscope designed to provide medical professionals with immediate feedback on the presence of middle ear infections (Otitis Media), a prevalent condition among pediatric patients. IR-Med Inc. operates from its headquarters in Rosh Pina, Israel.
株価
$0.0021
最終同期: 2026-08-12
時価総額
$162.20K
変化（1日）
0.00%
変化（1年）
-88.20%
国
IL
取引 IR-Med Inc. (IRME)

カテゴリー

Healthcare
IR-Med Inc.（IRME）の収益
Aug 2026 時点の収益 TTM: 0
IR-Med Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
IR-Med Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US